Senate Spending Bill Continues State Medical Marijuana Protections, Omits House Anti-Rescheduling Rider

November 13, 2026 at 9:39 am|By nuggnotes Media
The U.S. Capitol at dusk above a bill document in a leather folder

The Senate Appropriations Committee posted its draft FY2027 Justice Department spending bill on November 12, continuing longstanding state medical marijuana protections and leaving out a House provision that would block federal funding for marijuana rescheduling. The bill has not yet been voted on.

State protections remain in the Senate draft

The Senate Appropriations Committee released a draft of its fiscal 2027 Commerce, Justice, Science, and Related Agencies spending bill on Thursday, November 12, 2026 — a draft prepared for the committee's markup, carrying the placeholder number S. 0000. The committee has not yet scheduled a vote on the proposal, or on any of the five spending bills it released that day.

Section 531 continues a federal spending restriction first enacted in December 2014, preventing the Department of Justice from using funds to interfere with listed states implementing their own medical marijuana laws.

The provision covers 48 states, including New Mexico, along with the District of Columbia, Puerto Rico, Guam, the U.S. Virgin Islands and the Northern Mariana Islands. Idaho and Kansas are excluded. The draft also adds Nebraska, which is not covered by the current version of the law.

The Senate leaves out two House restrictions

The Senate draft does not include two provisions in the House Appropriations Committee's reported version of the bill, H.R. 8845.

One would prohibit federal funding from being used to reschedule marijuana or remove it from the Controlled Substances Act schedules. The other would expressly preserve federal enforcement of enhanced penalties under 21 U.S.C. § 860 for specified drug offenses within 1,000 feet of protected locations, including schools, colleges, playgrounds and public housing facilities, despite the medical marijuana protections.

The Justice Department has already placed qualifying state-licensed medical marijuana products and FDA-approved marijuana products in Schedule III. Broader rescheduling of marijuana remains in a separate DEA administrative proceeding.

Hemp and cannabis seizures also appear

Section 530 continues a separate longstanding protection for state industrial hemp research programs against Justice Department and DEA interference.

The draft committee report would direct the Justice Department to report within 90 days of enactment on illegal marijuana growing operations associated with foreign nationals, including potential links to Chinese transnational criminal organizations.

A separate draft Homeland Security spending report would direct Customs and Border Protection to brief Congress within 120 days of enactment on cannabis seizures, including products held by distributors complying with state or tribal law. Those seizures have drawn litigation and criticism from New Mexico Governor Michelle Lujan Grisham.

Congress faces a December deadline

The existing medical marijuana protections currently operate under temporary federal funding that expires December 11, 2026.

Congress has less than a month to pass the fiscal 2027 spending bills or approve another extension. The Senate committee's posted language is a proposal, not enacted law.

Sources

  • U.S. Senate Appropriations Committee, fiscal 2027 Commerce, Justice, Science, and Related Agencies bill text (Sections 530 and 531), posted November 12, 2026 Link
  • Marijuana Moment, "Senate Panel Proposes Extending State Medical Marijuana Protections, Without House's Anti-Rescheduling Provision," November 13, 2026 Link

Senate CJS rider by the numbers: 48 states covered, Idaho and Kansas out, Nebraska added, 90-day DOJ report

0 comments

Leave a comment